A reflective process led by a family physician to develop a renal-protection surveillance tool for HIV patients newly started on dolutegravir | Zendy

Junaid Omar | Zendy; Izak Loftus | Zendy; Nabeelah Vallie | Zendy; Richard B. Whitmore | Zendy; Gaironesa Solomon | Zendy; Michelle Powell | Zendy; Samela Mniki | Zendy; Mosedi Namane | Zendy

Open Access

A reflective process led by a family physician to develop a renal-protection surveillance tool for HIV patients newly started on dolutegravir

Author(s) -

Junaid Omar,

Izak Loftus,

Nabeelah Vallie,

Richard B. Whitmore,

Gaironesa Solomon,

Michelle Powell,

Samela Mniki,

Mosedi Namane

Publication year - 2021

Publication title -

african journal of primary health care and family medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.654

H-Index - 20

eISSN - 2071-2936

pISSN - 2071-2928

DOI - 10.4102/phcfm.v13i1.3088

Subject(s) - dolutegravir , medicine , human immunodeficiency virus (hiv) , pre exposure prophylaxis , family medicine , antiretroviral therapy , intensive care medicine , men who have sex with men , viral load , syphilis

A group of Vanguard Community Health Centre doctors embarked on a Health System's Improvement (HSI) project with the aim of reducing harm to renal function in patients who were either commenced on or switched to a dolutegravir (DTG)-based antiretroviral therapy (ART) regimen since 2019, when the usual monitoring and evaluation of ART-regimen switches were disrupted by the coronavirus disease 2019 (COVID-19) pandemic. This intended harm-reduction exercise, involving a reflective process that was facilitated by the family physician, led to the development of a Vanguard Renal Protection Surveillance tool, which is now used at Vanguard to detect and prevent renal decline.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research